Previous studies have also confirmed that plasma cystatin C and alpha-1-microglobulin (A1M) can be used as early and sensitive markers of renal injury in patients with HFRS and can predict AKI [25,26]. The gene discussed is AMBP; the disease is acute kidney injury.